{"id":464,"date":"2025-07-03T11:08:30","date_gmt":"2025-07-03T11:08:30","guid":{"rendered":"https:\/\/luckychemicals.com\/pharma\/?post_type=product&p=464"},"modified":"2026-02-04T10:57:02","modified_gmt":"2026-02-04T10:57:02","slug":"intermediates-apis","status":"publish","type":"product","link":"https:\/\/luckychemicals.com\/pharma\/product\/intermediates-apis\/","title":{"rendered":"Intermediates & APIs"},"content":{"rendered":"\n

As a GMP, GLP, and FDA-compliant<\/strong> manufacturer, Lucky Chemicals offers both high-quality pharmaceutical intermediates<\/strong> and active pharmaceutical ingredients (APIs)<\/strong> designed for regulated synthesis, formulation, and finished drug production. Our products are developed with precision, purity, and strict adherence to international regulatory requirements, catering to the demanding needs of the pharmaceutical and fine chemical industries<\/strong>.<\/p>\n\n\n\n

We combine controlled production systems<\/strong> with full regulatory support<\/strong> to ensure every batch meets the necessary quality, consistency, and documentation<\/strong> standards to support your manufacturing and formulation goals.<\/p>\n\n\n\n

Product Portfolio<\/strong><\/h3>\n\n\n\n

Intermediates<\/strong><\/h4>\n\n\n\n
Intermediate<\/th>CAS No.<\/th>Application<\/th><\/tr><\/thead>
n,n-Dimethylformamide Dimethyl Acetal<\/td>4637-24-5<\/td>Key intermediate for API synthesis, especially in heterocyclic and nitrogen-containing compounds<\/td><\/tr>
1-Piperidino-1-Cyclohexene<\/td>2981-10-4<\/td>Used in synthesis of active pharmaceutical ingredients and complex chemical structures<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

APIs<\/strong><\/h4>\n\n\n\n
API<\/th>CAS No.<\/th>Pharmacopoeia Standards<\/th>Application<\/th><\/tr><\/thead>
Allopurinol<\/td>315-30-0<\/td>IP \/ BP \/ EP \/ USP<\/td>Used to treat gout and high uric acid levels in patients undergoing chemotherapy or with kidney stones<\/td><\/tr>
Glimepiride<\/td>93479-97-1<\/td>IP \/ BP \/ EP \/ USP<\/td>Oral antidiabetic agent for the treatment of type 2 diabetes mellitus<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Key Features<\/strong><\/h3>\n\n\n\n